ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 170 filers reported holding ARGENX SE in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,474 | +15.9% | 104,700 | -8.2% | 0.09% | +37.5% |
| Q2 2023 | $44,429 | +19.7% | 114,000 | +14.5% | 0.06% | +30.6% |
| Q1 2023 | $37,109 | +16.5% | 99,600 | +18.4% | 0.05% | +11.4% |
| Q4 2022 | $31,860 | -99.1% | 84,100 | +693.4% | 0.04% | +780.0% |
| Q3 2022 | $3,742,000 | -65.5% | 10,600 | -70.5% | 0.01% | -64.3% |
| Q3 2021 | $10,834,000 | +21.6% | 35,874 | +21.2% | 0.01% | +27.3% |
| Q2 2021 | $8,912,000 | -1.1% | 29,600 | -9.5% | 0.01% | 0.0% |
| Q1 2021 | $9,011,000 | -55.4% | 32,722 | -52.4% | 0.01% | -50.0% |
| Q4 2020 | $20,204,000 | -18.9% | 68,700 | -27.6% | 0.02% | -12.0% |
| Q3 2020 | $24,913,000 | -14.9% | 94,900 | -27.0% | 0.02% | 0.0% |
| Q2 2020 | $29,283,000 | +332.7% | 130,014 | +153.1% | 0.02% | +257.1% |
| Q1 2020 | $6,767,000 | +68.0% | 51,373 | +104.7% | 0.01% | +133.3% |
| Q4 2019 | $4,028,000 | +38.6% | 25,091 | -1.6% | 0.00% | +50.0% |
| Q3 2019 | $2,906,000 | -75.1% | 25,500 | -69.1% | 0.00% | -80.0% |
| Q2 2019 | $11,666,000 | +116.8% | 82,400 | +91.2% | 0.01% | +100.0% |
| Q1 2019 | $5,381,000 | +58.4% | 43,100 | -3.8% | 0.01% | +66.7% |
| Q3 2018 | $3,398,000 | -85.2% | 44,800 | -84.1% | 0.00% | -76.9% |
| Q2 2018 | $22,967,000 | +61.2% | 282,355 | +59.4% | 0.01% | -18.8% |
| Q1 2018 | $14,250,000 | +35.3% | 177,155 | +6.2% | 0.02% | +33.3% |
| Q4 2017 | $10,533,000 | – | 166,827 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |